Showing results (91-100 of 345) with videos related to
Sort By:
Pageof 35
The Journal of Contemporary Dental Practice|June 3, 2022
Comparative Evaluation of Antibacterial Efficacy of Silver and Cadmium Nanoparticles and Calcium Hydroxide against Enterococcus faecalis BiofilmSonal Singh Arora, Rajesh Shetty, Manjunath Sushilamma Hemagiriyappa, et al.Trials|January 6, 2011
A Polypill for primary prevention of cardiovascular disease: a feasibility study of the World Health OrganizationElsayed Z Soliman, Shanthi Mendis, Wasantha P Dissanayake, et al.Circulation. Cardiovascular Quality and Outcomes|April 14, 2011
A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B as markers of cardiovascular riskAllan D Sniderman, Ken Williams, John H Contois, et al.Circulation|March 27, 2002
Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factorsFrank M Sacks, Andrew M Tonkin, Timothy Craven, et al.Stroke|October 5, 2002
Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health StudyW T Longstreth, Corinne Dulberg, Teri A Manolio, et al.Annals of Internal Medicine|September 3, 2002
Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack TrialBarry R Davis, Jeffrey A Cutler, Curt D Furberg, et al.The American Journal of Managed Care|August 10, 2007
Controlling prescription drug expenditures: a report of successDavid P Miller, Curt D Furberg, Ronald H Small, et al.Journal of the American Heart Association|April 16, 2014
Relations of change in plasma levels of LDL-C, non-HDL-C and apoB with risk reduction from statin therapy: a meta-analysis of randomized trialsGeorge Thanassoulis, Ken Williams, Keying Ye, et al.Drug Safety|April 3, 2009
Bisphosphonates and atrial fibrillation: systematic review and meta-analysisYoon Kong Loke, Vinodh Jeevanantham, Sonal SinghAmerican Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 24, 2019
Real World Outcomes Associated with Idarucizumab: Population-Based Retrospective Cohort StudySonal Singh, Amit Nautiyal, Kathy W BelkPageof 35